OnKure Therapeutics (OKUR) Depreciation & Amortization (CF) (2020 - 2026)

OnKure Therapeutics (OKUR) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $104000.0 in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 11.86% year-over-year to $104000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $433000.0 (down 6.48% YoY) and the FY2025 annual result came in at $447000.0, down 2.61% from the prior year.
• Depreciation & Amortization (CF) was little changed at $104000.0 in Q1 2026, from $104000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $291000.0 in Q4 2023 to a low of $19000.0 in Q1 2022.
• A 5-year average of $89117.6 and a median of $104000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) jumped 1064.0% — and 2024, when it plunged 60.14%.
• Tracing OKUR's Depreciation & Amortization (CF) over 5 years: stood at $25000.0 in 2022, then jumped by 1064.0% to $291000.0 in 2023, then sank by 60.14% to $116000.0 in 2024, then decreased by 10.34% to $104000.0 in 2025, then changed by 0.0% to $104000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $104000.0 (Q1 2026), $104000.0 (Q4 2025), and $108000.0 (Q3 2025), per Business Quant data.